PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: <em>Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study</em>
AID  - 10.1136/jitc-2019-000437corr1
DP  - 2020 Jul 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e000437corr1
VI  - 8
IP  - 2
4099  - http://jitc.bmj.com/content/8/2/e000437corr1.short
4100  - http://jitc.bmj.com/content/8/2/e000437corr1.full
SO  - J Immunother Cancer2020 Jul 01; 8